Combined therapy with probiotic VSL#3 and Omega-3 fatty acids attenuates colonic injury and inflammation in chronic DNBS-induced colitis in mice (vol 69, pg 135, 2021)
| dc.authorid | 0000-0001-9416-7757 | |
| dc.contributor.author | Yoldaş İlktaç, Havvanur | |
| dc.contributor.author | Kızıltan, Gül | |
| dc.contributor.author | Devrim Lanpir, Aslı | |
| dc.contributor.author | Ozansoy, Mehmet | |
| dc.contributor.author | Günal, Mehmet Yalçın | |
| dc.contributor.author | Özmen Toğay, Sine | |
| dc.contributor.author | Keskin, İlknur | |
| dc.contributor.author | Özdemir, Ekrem Musa | |
| dc.contributor.author | Kılıç, Ülkan | |
| dc.date.accessioned | 2022-05-27T09:15:14Z | |
| dc.date.available | 2022-05-27T09:15:14Z | |
| dc.date.issued | 2022 | |
| dc.department | İstanbul Medipol Üniversitesi, Rektörlük, Tıbbi Araştırma Merkezi (MEDİTAM) | |
| dc.description.abstract | We published the abovementioned article about probiotic mixture VSL#3 on October 6, 2021. Since the product was named VSL#3 in our purchasing process in early 2016, it is referred to as VSL#3 in our article. In addition, the product currently known as VSL#3 is not the same as De Simone Formulation. De Simone Formulation is now available as Visbiome® in the United States and Vivomixx® in Europe. The authors would like to apologise for any inconvenience caused. | |
| dc.identifier.citation | Yoldaş İlktaç, H., Kızıltan, G., Devrim Lanpir, A., Ozansoy, M., Günal, M. Y., Özmen Toğay, S. ... Kılıç, Ü. (2022). Combined therapy with probiotic VSL#3 and Omega-3 fatty acids attenuates colonic injury and inflammation in chronic DNBS-induced colitis in mice (vol 69, pg 135, 2021). Folia Biologica-Krakow, 70(1), 43-43. https://doi.org/10.3409/fb_70-1.05 | |
| dc.identifier.doi | 10.3409/fb_70-1.05 | |
| dc.identifier.endpage | 43 | |
| dc.identifier.issn | 0015-5497 | |
| dc.identifier.issn | 1734-9168 | |
| dc.identifier.issue | 1 | |
| dc.identifier.scopus | 2-s2.0-85130591657 | |
| dc.identifier.scopusquality | N/A | |
| dc.identifier.startpage | 43 | |
| dc.identifier.uri | https://doi.org/10.3409/fb_70-1.05 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12511/9474 | |
| dc.identifier.volume | 70 | |
| dc.identifier.wos | 000792884400005 | en_US |
| dc.identifier.wosquality | Q4 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.institutionauthor | Özdemir, Ekrem Musa | |
| dc.language.iso | en | |
| dc.publisher | Polish Academy of Sciences | |
| dc.relation.ispartof | Folia Biologica-Krakow | en_US |
| dc.relation.publicationcategory | Diğer | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Omega-3 | |
| dc.subject | VSL#3 | |
| dc.subject | Fatty Acids | |
| dc.subject | DNBS-Induced Colitis | |
| dc.title | Combined therapy with probiotic VSL#3 and Omega-3 fatty acids attenuates colonic injury and inflammation in chronic DNBS-induced colitis in mice (vol 69, pg 135, 2021) | |
| dc.title.alternative | Corrigendum to: Combined therapy with probiotic VSL#3 and Omega-3 fatty acids attenuates colonic ınjury and ınflammation in Chronic DNBS-induced colitis in mice | |
| dc.type | Other |
